Ethocybin

Last updated
Ethocybin
Ethocybin.png
Ethocybin zwitterion 3D ball.png
Clinical data
Other names4-Phosphoryloxy-N,N-diethyltryptamine; CEY-19; 4-phosphoryloxy-DET; 4-PO-DET
Routes of
administration 		Oral [1]
Drug class Serotonin receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
Duration of action 4–6 hours [1]
Identifiers
  • Phosphoric acid mono-[3-(2-diethylamino-ethyl)-1H-indol-4-yl] ester
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
Formula C14H21N2O4P
Molar mass 312.306 g·mol−1
3D model (JSmol)
  • CCN(CC)CCC2=CNC1=CC=CC(OP(O)(O)=O)=C12
  • InChI=1S/C14H21N2O4P/c1-3-16(4-2)9-8-11-10-15-12-6-5-7-13(14(11)12)20-21(17,18)19/h5-7,10,15H,3-4,8-9H2,1-2H3,(H2,17,18,19) Yes check.svgY
  • Key:AAVKQQUBPHSCML-UHFFFAOYSA-N Yes check.svgY
   (verify)

Ethocybin (code name CEY-19), also known as 4-phosphoryloxy-N,N-diethyltryptamine (4-PO-DET), is a homologue of the mushroom alkaloid psilocybin, and a semi-synthetic psychedelic alkaloid of the tryptamine family. [1]

Contents

Pharmacology

Ethocybin may be dephosphorylated in vivo to 4-HO-DET (ethocin), analogously to how psilocybin is metabolized to psilocin. [2] This chemical reaction takes place under strongly acidic conditions or enzymatically by phosphatases in the body. 4-HO-DET acts as a partial agonist at the 5-HT2A serotonin receptor. [3] [4]

History

Albert Hofmann was the first to produce ethocybin, soon after his discovery of psilocin and psilocybin. [5] [6] It was first described by 1963. [5] [6] The drug was known under the code name CEY-19. [6]

United States

Ethocybin is not controlled in the United States, but possession or sale may be considered illegal under the Federal Analog Act.

Research

Ethocybin has been studied as a treatment for several disorders since the early 1960s, and numerous papers are devoted to this material.[ citation needed ] Its short-lived action was considered a virtue. A 2010 study found that ethocybin helped with bipolar affective disorder.[ citation needed ]

References

  1. 1 2 3 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252.
  2. ↑ "EMCDDA | Hallucinogenic mushrooms profile (chemistry, effects, other names (magic mushrooms, shrooms…), origin, mode of use, other names, medical use, control status)". www.emcdda.europa.eu. Retrieved 2020-01-22.
  3. ↑ "EMCDDA | Hallucinogenic mushrooms profile (chemistry, effects, other names (magic mushrooms, shrooms…), origin, mode of use, other names, medical use, control status)". www.emcdda.europa.eu. Retrieved 2020-01-22.
  4. ↑ Kozell LB, Eshleman AJ, Swanson TL, Bloom SH, Wolfrum KM, Schmachtenberg JL, Olson RJ, Janowsky A, Abbas AI (April 2023). "Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter". J Pharmacol Exp Ther. 385 (1): 62–75. doi:10.1124/jpet.122.001454. PMC   10029822 . PMID   36669875.
  5. 1 2 USpatent 3075992,Hofmann, Albert; Troxler, Franz.,"Esters of indoles",issued 1963-1-29
  6. 1 2 3 Leuner H, Baer G (1965). "Two new short-acting hallucinogens of the psilocybin group". Neuropsychopharmacology. 4: 471–474. Archived from the original on 2025-04-22.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.